Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma
β Scribed by Eric T. Shinohara; Adriana Gonzalez; Pierre P. Massion; Heidi Chen; Ming Li; Andrea S. Freyer; Sandra J. Olson; Jeremiah J. Andersen; Yu Shyr; David P. Carbone; David H. Johnson; Dennis E. Hallahan; Bo Lu
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 179 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Using immunohistochemistry, the authors prospectively investigated the expression of HERβ2/__neu__ protein in radically resected specimens of nonsmall cell lung carcinoma (NSCLC) and evaluated its impact on longβterm prognosis. ## METHODS Between January 1991 and Februa
antibodies, the authors immunostained sections of formalin fixed, paraffin embedded tissues from 289 Stage I NSCLCs. The Kaplan-Meier survival method, the log Department of Pathology, Baylor College of rank test, and Fisher's exact test were used for statistical analysis. Medicine and the Methodist
## Abstract ## BACKGROUND Glutathione Sβtransferase (GST) Ο (GSTP1) is a detoxification enzyme with substrate specificity for both exogenous carcinogens and chemotherapy agents. Genetic polymorphisms of __GSTP1__ exon 5 (Ile105Val) and exon 6 (Ala114Val) appear to reduce this enzyme's activity. Pr